Convergence Financial »

Belite Bio shares owned by Convergence Financial

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Convergence Financial from 13F filings

Historical chart of Convergence Financial investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Convergence Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Convergence Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $473k 3.0k 159.44

More positions owned by Convergence Financial

Spdr Series Trust State Street Spd (SPYV)
Spdr Series Trust State Street Spd (SPAB)
Spdr Series Trust State Street Spd (BIL)
Spdr Series Trust State Street Spd (MDYG)
Spdr Series Trust State Street Spd (MDYV)
Spdr Series Trust State Street Spd (SPYG)
J P Morgan Exchange Traded F Active Value Etf (JAVA)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Tesla Motors (TSLA)
Ishares Tr Msci Usa Mmentm (MTUM)
Franklin Templeton Etf Tr Invt Grade Corpt (FLCO)
Spdr Series Trust State Street Spd (SLYV)
Spdr Series Trust State Street Spd (SLYG)
Select Sector Spdr Tr State Street Tec (XLK)
Invesco Exch Traded Fd Tr Ii Short Term Treas (TBLL)

View all positions for Convergence Financial

Top funds holding Belite Bio

Darwin Global Management
Paradigm Biocapital Advisors
UBS Group
Rtw Investments
Millennium Management
Holocene Advisors
Eventide Asset Management
Deerfield Management Company
Morgan Stanley
Marshall Wace
Perceptive Advisors
Patient Square Capital
Duquesne Family Office
Goldman Sachs Group
MPM Oncology Impact Management

View all funds holding Belite Bio